Skip to main content
Veterinary Medicines

Aivlosin 625 mg/g - Granules (chickens and turkeys)

Authorised
  • Tylvalosin

Product identification

Medicine name:
Aivlosin 625 mg/g - Granules (chickens and turkeys)
Active substance:
  • Tylvalosin
Target species:
  • Turkey
  • Chicken
Route of administration:
  • In drinking water use

Product details

Active substance and strength:
  • Tylvalosin
    625.00
    milligram(s)
    /
    1.00
    gram(s)
Pharmaceutical form:
  • Granules for use in drinking water
Withdrawal period by route of administration:
  • In drinking water use
    • Turkey
      • Meat and offal
        2
        day
      • Eggs
        no withdrawal period
    • Chicken
      • Meat and offal
        2
        day
      • Egg
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01FA92
Authorisation status:
  • Valid
Authorised in:
  • Austria
  • Belgium
  • Bulgaria
  • Croatia
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Iceland
  • Ireland
  • Italy
  • Latvia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Malta
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)
Package description:
  • Packaging:Aluminium foil laminated sachet, Package_size:1 sachet, Content:400 g
  • Packaging:Aluminium foil laminated sachet, Package_size:1 sachet, Content:40 g

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • ECO Animal Health Europe Limited
Marketing authorisation date:
Manufacturing sites for batch release:
  • PROVET S.A.
  • Acme Drugs S.r.l.
Responsible authority:
  • European Commission
Authorisation number:
This information is not available for this product.
Date of authorisation status change:

Documents

Combined File of all Documents

English (PDF)
Published on: 28/08/2024
Download
Bulgarian (PDF)
Published on: 28/08/2024
Croatian (PDF)
Published on: 28/08/2024
Czech (PDF)
Published on: 28/08/2024
Danish (PDF)
Published on: 28/08/2024
Dutch (PDF)
Published on: 28/08/2024
Estonian (PDF)
Published on: 28/08/2024
Finnish (PDF)
Published on: 28/08/2024
French (PDF)
Published on: 28/08/2024
German (PDF)
Published on: 28/08/2024
Greek (PDF)
Published on: 28/08/2024
Hungarian (PDF)
Published on: 28/08/2024
Icelandic (PDF)
Published on: 28/08/2024
Italian (PDF)
Published on: 28/08/2024
Latvian (PDF)
Published on: 28/08/2024
Lithuanian (PDF)
Published on: 28/08/2024
Maltese (PDF)
Published on: 28/08/2024
Norwegian (PDF)
Published on: 28/08/2024
Polish (PDF)
Published on: 28/08/2024
Portuguese (PDF)
Published on: 28/08/2024
Romanian (PDF)
Published on: 28/08/2024
Slovak (PDF)
Published on: 28/08/2024
Slovenian (PDF)
Published on: 28/08/2024
Spanish (PDF)
Published on: 28/08/2024
Swedish (PDF)
Published on: 28/08/2024

ema-puar-aivlosin-wepar-v-083-wepar-x-0081-en.pdf

English (PDF)
Published on: 17/03/2023
Download

ema-puar-aivlosin-v-083-par-en.pdf

English (PDF)
Published on: 6/02/2023
Download

ema-puar-aivlosin-v-083-var-ii-0078-en.pdf

English (PDF)
Published on: 6/02/2023
Download

ema-puar-aivlosin-v-083-var-x-0051-en.pdf

English (PDF)
Published on: 6/02/2023
Download

ema-puar-aivlosin-v-083-var-ii-0064-en.pdf

English (PDF)
Published on: 6/02/2023
Download